Lilly Is Latest Target Of Philadelphia U.S. Attorney's Rx Investigation

Investigation into Lilly's marketing and promotional practices is focused on Evista, Prozac and Zyprexa, company says. Subpoenas may reflect Philadelphia prosecutor's interest in PBMs and Federal Employee Health Benefits Program.

More from Archive

More from Pink Sheet